Document is current
Any future updates will be listed below
-
Authors
Bangs, Rick https://orcid.org/0000-0002-0706-8775
Li, Roger https://orcid.org/0000-0003-1274-7200
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 21 November 2025
First Online: 15 December 2025
Declarations
:
: Rick Bangs: consulting fees and honoraria from AstraZeneca, Astellas, Gilead, Johnson and Johnson, Pfizer and travel support from AstraZeneca, Astellas, Gilead, Pfizer; Roger Li: grant funding from Predicine Inc, Veracyte CG Oncology, and Valar Labs, has received consulting fees from BMS, UroGen, Lucene, Merck, CG Oncology, and Thericon, has received support for travel from CG Oncology, and has stock in Crispr Therapeutics, Illumina, Eli Lily, and Guardant.
: This podcast article is based on data presented at AUA 2025 and does not contain any new studies with human participants or animals performed by the authors.
